                         SEQUENCE LISTING

<110>  INSERM
 
<120>  ANTI-NEUROTENSIN ANTIBODIES AND USES THEREOF

<130>  BIO14015 FORGEZ / MC

<160>  10    

<170>  PatentIn version 3.3

<210>  1
<211>  122
<212>  PRT
<213>  Artificial

<220>
<223>  VH sequence

<400>  1

Asp Val Lys Leu Val Glu Ser Gly Gly Gly Leu Val Lys Leu Gly Gly 
1               5                   10                  15      


Ser Leu Lys Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Gly Tyr 
            20                  25                  30          


Tyr Met Ser Trp Val Arg Gln Thr Pro Glu Lys Arg Leu Glu Leu Val 
        35                  40                  45              


Ala Ala Ile Asn Asn Tyr Gly Asp Asn Thr Asn Tyr Pro Asp Thr Val 
    50                  55                  60                  


Lys Gly Arg Phe Ser Val Ser Arg Asp Asn Ala Lys Asn Thr Leu Tyr 
65                  70                  75                  80  


Leu Glu Met Asn Ser Leu Lys Ser Glu Asp Thr Ala Leu Tyr Tyr Cys 
                85                  90                  95      


Ala Arg Leu Ala Asn Tyr Ala Asn Gln Arg Gly Ala Met Asp Tyr Trp 
            100                 105                 110         


Gly Gln Gly Thr Ser Val Thr Val Ser Ser 
        115                 120         


<210>  2
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR1

<400>  2

Gly Phe Thr Phe Ser Gly Tyr Tyr Met Ser 
1               5                   10  


<210>  3
<211>  17
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR2

<400>  3

Ala Ile Asn Asn Tyr Gly Asp Asn Thr Asn Tyr Pro Asp Thr Val Lys 
1               5                   10                  15      


Gly 
    


<210>  4
<211>  13
<212>  PRT
<213>  Artificial

<220>
<223>  H-CDR3

<400>  4

Leu Ala Asn Tyr Ala Asn Gln Arg Gly Ala Met Asp Tyr 
1               5                   10              


<210>  5
<211>  107
<212>  PRT
<213>  Artificial

<220>
<223>  VL sequence

<400>  5

Asp Ile Gln Met Thr His Thr Thr Ser Ser Leu Ser Ala Ser Leu Gly 
1               5                   10                  15      


Asp Arg Val Thr Ile Ser Cys Arg Ala Ser Gln Asp Ile Ala Asn Tyr 
            20                  25                  30          


Leu Asn Trp Tyr Gln Gln Lys Pro Asp Gly Thr Val Thr Leu Leu Ile 
        35                  40                  45              


Tyr Tyr Thr Ser Arg Leu His Ser Gly Val Pro Ser Arg Phe Ser Gly 
    50                  55                  60                  


Ser Gly Ser Gly Thr Asp Tyr Ser Leu Thr Ile Asn Asn Leu Asp Gln 
65                  70                  75                  80  


Glu Asp Ile Ala Thr Tyr Phe Cys Gln Gln Gly Tyr Thr Leu Pro Pro 
                85                  90                  95      


Thr Phe Gly Gly Gly Thr Lys Leu Glu Ile Lys 
            100                 105         


<210>  6
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR1

<400>  6

Arg Ala Ser Gln Asp Ile Ala Asn Tyr Leu Asn 
1               5                   10      


<210>  7
<211>  7
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR2

<400>  7

Tyr Thr Ser Arg Leu His Ser 
1               5           


<210>  8
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  L-CDR3

<400>  8

Gln Gln Gly Tyr Thr Leu Pro Pro Thr 
1               5                   


<210>  9
<211>  170
<212>  PRT
<213>  Homo sapiens

<400>  9

Met Met Ala Gly Met Lys Ile Gln Leu Val Cys Met Leu Leu Leu Ala 
1               5                   10                  15      


Phe Ser Ser Trp Ser Leu Cys Ser Asp Ser Glu Glu Glu Met Lys Ala 
            20                  25                  30          


Leu Glu Ala Asp Phe Leu Thr Asn Met His Thr Ser Lys Ile Ser Lys 
        35                  40                  45              


Ala His Val Pro Ser Trp Lys Met Thr Leu Leu Asn Val Cys Ser Leu 
    50                  55                  60                  


Val Asn Asn Leu Asn Ser Pro Ala Glu Glu Thr Gly Glu Val His Glu 
65                  70                  75                  80  


Glu Glu Leu Val Ala Arg Arg Lys Leu Pro Thr Ala Leu Asp Gly Phe 
                85                  90                  95      


Ser Leu Glu Ala Met Leu Thr Ile Tyr Gln Leu His Lys Ile Cys His 
            100                 105                 110         


Ser Arg Ala Phe Gln His Trp Glu Leu Ile Gln Glu Asp Ile Leu Asp 
        115                 120                 125             


Thr Gly Asn Asp Lys Asn Gly Lys Glu Glu Val Ile Lys Arg Lys Ile 
    130                 135                 140                 


Pro Tyr Ile Leu Lys Arg Gln Leu Tyr Glu Asn Lys Pro Arg Arg Pro 
145                 150                 155                 160 


Tyr Ile Leu Lys Arg Asp Ser Tyr Tyr Tyr 
                165                 170 


<210>  10
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  antigen peptide

<400>  10

Cys Gln Leu Tyr Glu Asn Lys Pro Arg Arg Pro Tyr Ile Leu 
1               5                   10                  


